As biopharma companies continue to cope with the COVID-19 pandemic and position themselves for recovery, digital and analytics can be a powerful tool in manufacturing and operations. It can drive the next wave of business optimization by transforming operational performance, shortening time to market, improving quality and yield, reducing supply chain volatility, and accelerating technology transfers.